By Ilana Heckler, PhD and Maite Sabalza, PhD
LEARNING OBJECTIVES
Upon completion of this article, the reader will be able to:
- Discuss the viral family, prevalence, and transmission route of cytomegalovirus (CMV).
- List the vulnerable populations and complications of CMV transmission.
- Describe CMV testing currently used in prenatal, fetal, and newborn testing.
- Discuss future suggestions for the screening of newborns for CMV and its utility worldwide.
About the Authors
Ilana Heckler, PhD, is the Scientific Affairs Liaison at EUROIMMUN US. She holds a PhD in Chemical Biology for her studies on bacterial hemoprotein sensors of nitric oxide. As the Scientific Affairs Liaison, Dr. Heckler establishes scientific collaborations and assists in the validation of diagnostic assays for autoimmune and infectious diseases.
Maite Sabalza, PhD, is the Scientific Affairs Manager at EUROIMMUN US. Her academic background is in infectious diseases and diagnostics. In her role at EUROIMMUN US, she establishes relationships with key opinion leaders and supports the team with commercial activities including scientific collaborations, scientific marketing, and business development of diagnostics.
Photo credit: Image courtesy of EUROIMMUN US
Course Includes
- 1 Lesson
- 1 Test
- Course Certificate
Level of Instruction: Intermediate
Medical Laboratory Observer (MLO) is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program.
Level of Instruction: Intermediate
Passing scores of 70 percent or higher are eligible for 1 contact hour of P.A.C.E. credit. This test is no longer valid for CEs after June 30, 2024.
